Splenic irradiation in chronic myeloid leukemia

S. Hukku, H. A. Baboo, S. Venkataratnam, M. S. Vidyasagar, N. L. Patel

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Results of splenic irradiation as the initial and only method of treatment are reported in 25 patients with chronic myeloid leukemia. Peripheral remission was induced in all the patients. Induction was achieved after a short period of 11 to 30 days in the majority of the patients, the longest period being 40 days. Several patients were in remission 9 months after treatment. The results are compared with those obtained by chemotherapy. Some advantages of splenic irradiation over chemotherapy are emphasized.

Original languageEnglish
Pages (from-to)9-12
Number of pages4
JournalActa Radiologica. Oncology Radiation Therapy Physics and Biology
Volume22
Issue number1
Publication statusPublished - 25-08-1983

Fingerprint

Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Drug Therapy
Therapeutics

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

Hukku, S. ; Baboo, H. A. ; Venkataratnam, S. ; Vidyasagar, M. S. ; Patel, N. L. / Splenic irradiation in chronic myeloid leukemia. In: Acta Radiologica. Oncology Radiation Therapy Physics and Biology. 1983 ; Vol. 22, No. 1. pp. 9-12.
@article{f7c5c2afc7984c039fcffa29a0641492,
title = "Splenic irradiation in chronic myeloid leukemia",
abstract = "Results of splenic irradiation as the initial and only method of treatment are reported in 25 patients with chronic myeloid leukemia. Peripheral remission was induced in all the patients. Induction was achieved after a short period of 11 to 30 days in the majority of the patients, the longest period being 40 days. Several patients were in remission 9 months after treatment. The results are compared with those obtained by chemotherapy. Some advantages of splenic irradiation over chemotherapy are emphasized.",
author = "S. Hukku and Baboo, {H. A.} and S. Venkataratnam and Vidyasagar, {M. S.} and Patel, {N. L.}",
year = "1983",
month = "8",
day = "25",
language = "English",
volume = "22",
pages = "9--12",
journal = "Acta Oncologica",
issn = "0284-186X",
publisher = "Informa Healthcare",
number = "1",

}

Hukku, S, Baboo, HA, Venkataratnam, S, Vidyasagar, MS & Patel, NL 1983, 'Splenic irradiation in chronic myeloid leukemia', Acta Radiologica. Oncology Radiation Therapy Physics and Biology, vol. 22, no. 1, pp. 9-12.

Splenic irradiation in chronic myeloid leukemia. / Hukku, S.; Baboo, H. A.; Venkataratnam, S.; Vidyasagar, M. S.; Patel, N. L.

In: Acta Radiologica. Oncology Radiation Therapy Physics and Biology, Vol. 22, No. 1, 25.08.1983, p. 9-12.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Splenic irradiation in chronic myeloid leukemia

AU - Hukku, S.

AU - Baboo, H. A.

AU - Venkataratnam, S.

AU - Vidyasagar, M. S.

AU - Patel, N. L.

PY - 1983/8/25

Y1 - 1983/8/25

N2 - Results of splenic irradiation as the initial and only method of treatment are reported in 25 patients with chronic myeloid leukemia. Peripheral remission was induced in all the patients. Induction was achieved after a short period of 11 to 30 days in the majority of the patients, the longest period being 40 days. Several patients were in remission 9 months after treatment. The results are compared with those obtained by chemotherapy. Some advantages of splenic irradiation over chemotherapy are emphasized.

AB - Results of splenic irradiation as the initial and only method of treatment are reported in 25 patients with chronic myeloid leukemia. Peripheral remission was induced in all the patients. Induction was achieved after a short period of 11 to 30 days in the majority of the patients, the longest period being 40 days. Several patients were in remission 9 months after treatment. The results are compared with those obtained by chemotherapy. Some advantages of splenic irradiation over chemotherapy are emphasized.

UR - http://www.scopus.com/inward/record.url?scp=0020533486&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020533486&partnerID=8YFLogxK

M3 - Article

VL - 22

SP - 9

EP - 12

JO - Acta Oncologica

JF - Acta Oncologica

SN - 0284-186X

IS - 1

ER -